Sign Out
Each mL of concentrate contains 25 mg of bevacizumab*.
Each vial of 4 mL of concentrate contains 100 mg of bevacizumab.
Each vial of 16 mL of concentrate contains 400 mg of bevacizumab.
For dilution and other handling recommendations, see Special precautions for disposal and other handling under Cautions for Usage.
*Bevacizumab is a recombinant humanised monoclonal antibody produced by DNA technology in Chinese Hamster Ovary cells.
Excipients/Inactive Ingredients: Trehalose dihydrate, Sodium phosphate, Polysorbate 20, Water for injections.
Continue with Google